Chronic Spontaneous Urticaria (CSU)
Symptoms, Doctors, Treatments, Advances & More

Chronic Spontaneous Urticaria (CSU) Overview

Save information for later
Sign Up

Learn About Chronic Spontaneous Urticaria (CSU)

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Chronic Spontaneous Urticaria (CSU) Local Doctors?
Giselle Mosnaim
Elite in Chronic Spontaneous Urticaria (CSU)
Allergy and Immunology
Elite in Chronic Spontaneous Urticaria (CSU)
Allergy and Immunology

Endeavor Health Medical Group

2050 Pfingsten Rd., Suite 360, 
Glenview, IL 
Languages Spoken:
English, Spanish

Giselle Mosnaim, MD, an allergist and immunologist at Endeavor Health, treats conditions such as asthma, allergic rhinitis, eczema and chronic hives. Drawing from her personal and family experience with allergies, she offers compassionate, evidence-based care tailored to each patient's lifestyle. In addition to seeing patients, Dr. Mosnaim leads clinical research on biologics and digital tools for allergy and asthma treatment. Dr. Mosnaim is rated as an Elite provider by MediFind in the treatment of Chronic Spontaneous Urticaria (CSU). Her top areas of expertise are Chronic Spontaneous Urticaria (CSU), Asthma, Hives, and Vibratory Urticaria.

Eric T. Oliver
Elite in Chronic Spontaneous Urticaria (CSU)
Allergy and Immunology
Elite in Chronic Spontaneous Urticaria (CSU)
Allergy and Immunology

Johns Hopkins Bayview Medical Center

Baltimore, MD 
Experience:
18+ years
Languages Spoken:
English
Offers Telehealth

Eric Oliver, M.D. joined the Division of Allergy and Clinical Immunology as an instructor of medicine in July 2015. Dr. Oliver was born and raised in South Carolina and graduated from Duke University as dual major in biology and religion and a music minor. He earned his M.D. from the University of South Carolina and completed his residency in internal medicine and pediatrics from The Ohio State University. He completed his fellowship in allergy and immunology at Johns Hopkins. Dr. Oliver evaluates and treats infants, children, and adults at the Johns Hopkins Asthma & Allergy Center located on the Bayview campus. His clinical interests include allergic disorders of the skin and airway, hives (urticaria), food allergy, anaphylaxis, immunotherapy, aspirin desensitization, and novel therapeutics. His research efforts focus on elucidating the mechanisms for cell activation and recruitment in allergic skin disorders. Dr. Oliver is rated as an Elite provider by MediFind in the treatment of Chronic Spontaneous Urticaria (CSU). His top areas of expertise are Chronic Spontaneous Urticaria (CSU), Hives, Mast Cell Activation Syndrome (MCAS), and Asthma.

 
 
 
 
Learn about our expert tiers
Learn More
Sarbjit S. Saini
Elite in Chronic Spontaneous Urticaria (CSU)
Allergy and Immunology
Elite in Chronic Spontaneous Urticaria (CSU)
Allergy and Immunology

Johns Hopkins Bayview Medical Center

Baltimore, MD 
Languages Spoken:
English

Dr. Saini joined faculty of the Division of Allergy & Clinical Immunology immediately following his fellowship in 1997. He has served as the principal investigator and co-investigator for basic and translational studies examining the role of IgE receptor expression and activation in allergic airways disease, anaphylaxis, and chronic urticaria. His research has been supported by the NIH, American Lung Association, and the AAAAI. He is the Program Director for our allergy and immunology fellowship program since 2008. Dr. Saini is rated as an Elite provider by MediFind in the treatment of Chronic Spontaneous Urticaria (CSU). His top areas of expertise are Chronic Spontaneous Urticaria (CSU), Hives, Angioedema, and Hypereosinophilic Syndrome.

What are the latest Chronic Spontaneous Urticaria (CSU) Clinical Trials?
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab in Patients With Chronic Spontaneous Urticaria Who Remain Symptomatic Despite H1 Antihistamine Treatment (EMBARQ-CSU2)

Summary: The purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urticaria (CSU) inadequately controlled by non-sedating second generation H1-antihistamines in comparison to placebo.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Randomized, Double-Blind, Placebo Controlled, Dose-Ranging Study Evaluating the Efficacy and Safety of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria

Summary: This study will evaluate the efficacy and safety of different doses of EVO756 in adults with moderate to severe chronic spontaneous urticaria (CSU).